Nourish
Dietitian platform Nourish raised funding to support GLP-1 patients with nutrition guidance. See round details, amount, and latest 2026 investment data.
Overview
Nourish is a healthcare company focused on connecting GLP-1 patients with dietitians as use of weight loss drugs expands. Its offering targets people taking GLP-1 medications who need nutrition support alongside pharmacological treatment. The company’s positioning centers on broad dietitian access for this fast-growing patient population. Menlo Ventures led a $100 million undisclosed round in May 2026, bringing reported funding to $100 million.
Funding History
Menlo Ventures leads $100M round in Nourish to give every GLP-1 patient a dietitian as weight loss drugs take off
Frequently Asked Questions
- How much funding does AI Funding track for Nourish?
- AI Funding tracks $100M for Nourish across 1 funding round in this database.
- Who are Nourish's investors?
- Nourish's investors include Index Ventures, Thrive Capital, Menlo Ventures, Y Combinator, BoxGroup, and 5 others.
- What does Nourish do?
- Nourish is a healthcare company focused on connecting GLP-1 patients with dietitians as use of weight loss drugs expands. Its offering targets people taking GLP-1 medications who need nutrition support alongside pharmacological treatment. The company’s positioning centers on broad dietitian access for this fast-growing patient population. Menlo Ventures led a $100 million undisclosed round in May 2026, bringing reported funding to $100 million.
- Where is Nourish headquartered?
- Nourish is headquartered in San Francisco, CA.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.